Vermillion Posts Q3 Revenue Decline, Acquires Assets of Correlogic
November 09, 2011
Vermillion Posts Q3 Revenue Decline, Acquires Assets of Correlogic
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Vermillion Completes Acquisition of Correlogic Ovarian Cancer Dx Business
December 19, 2011 / GenomeWeb Daily News - Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor - Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
May 17, 2013 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor